छोड़कर सामग्री पर जाएँ

Rakesh Jhunjhunwala-backed Concord Biotech files draft papers to float IPO

The active pharmaceutical ingredients (API) maker is also backed by ace investor Rakesh Jhunjhunwalal who died on Sunday. Jhunjhunwala holds over 24% stake in the firm through its investment arm Rare Enterprises

Read More

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी